While the Bridge is an important milestone, it should also be a catalyst for creating a permanent pathway to comprehensive obesity care within Medicare and across private insurance as well." Following the announcement, Novo Nordisk says it is working with CMS, healthcare professionals, pharmacists and patient advocacy organizations to support the program's rollout
Next Steps States may pass laws requiring this coverage for insured plans, but for now employers that voluntarily cover GLP-1 drugs may wish to track the number of employees using the benefit and the annual cost
The side effect comparison between semaglutide and tirzepatide provides additional context on GLP-1 tolerability patterns
Demand for GLP-1 receptor agonists is expected to grow at an 11.7% CAGR between 2026 and 2036
For Wegovy pricing and availability, see our Wegovy treatment page
Recent warnings from the FDA and political leaders have reignited public anxiety about whether acetaminophen (Tylenol) use during pregnancy increases the risk of autism or ADHD in children
